Journal For Immunotherapy Of Cancer

雜志介紹

Journal For Immunotherapy Of Cancer雜志介紹

《Journal For Immunotherapy Of Cancer》是一本以English為主的開放獲取國際優(yōu)秀期刊，中文名稱癌癥免疫治療雜志，本刊主要出版、報(bào)道醫(yī)學(xué)-IMMUNOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為10.3，最新CiteScore 指數(shù)為17.7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation

  Author: Zhang, Biying; Li, Jiao; Hua, Qingling; Wang, Haihong; Xu, Guojie; Chen, Jiayuan; Zhu, Ying; Li, Ruiqi; Liang, Qing; Wang, Lanqing; Jin, Min; Tang, Jing; Lin, Zhenyu; Zhao, Lei; Zhang, Dejun; Yu, Dandan; Ren, Jinghua; Zhang, Tao

• Novel combination strategy of high intensity focused ultrasound (HIFU) and checkpoint blockade boosted by bioinspired and oxygen-supplied nanoprobe for multimodal imaging-guided cancer therapy

  Author: Tang, Rui; He, Hongye; Lin, Xiaohong; Wu, Nianhong; Wan, Li; Chen, Qiaoqi; Hu, Yaqin; Cheng, Chen; Cao, Yuting; Guo, Xun; Zhou, Ying; Xiong, Xialin; Zheng, Min; Wang, Qi; Li, Faqi; Zhou, Yang; Li, Pan

• Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy

  Author: Shi, Lin; Lu, Jinying; Zhong, Da; Song, Meijuan; Liu, Jian; You, Wenhua; Li, Wen-Hui; Lin, Lin; Shi, Dongyan; Chen, Yun

• STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer

  Author: Ding, Liya; Wang, Qiwei; Martincuks, Antons; Kearns, Michael J.; Jiang, Tao; Lin, Ziying; Cheng, Xin; Qian, Changli; Xie, Shaozhen; Kim, Hye-Jung; Launonen, Inga-Maria; Faerkkilae, Anniina; Roberts, Thomas M.; Freeman, Gordon J.; Liu, Joyce F.; Konstantinopoulos, Panagiotis A.; Matulonis, Ursula; Yu, Hua; Zhao, Jean J.

英文介紹

Journal For Immunotherapy Of Cancer雜志英文介紹

Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.